glp-1 drugs key developments 2025 2.0: Where the Next Wave of Value Will Be Created GLP-1 Drug Market Size &
Description
How neuroinflammation contributes to neurodegeneration
One of the more recent developments is the introduction of glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
This model helps patients develop lasting habits while on treatment, which supports long-term success whether medication continues or is eventually tapered
[(accessed on 13 March 2024)];BMJ Open
Examples include yogurt, kefir, bananas, and onions
Additional information Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
